Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China
· Delayed Price · Currency is CNY 54.40
+1.53 (2.89%)
May 16, 2025, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 12.23 billion as of May 16, 2025. Its market cap has increased by 12.49% in one year.
Market Cap
12.23B
Enterprise Value
13.32B
Revenue
1.83B
Ranking
n/a
PE Ratio
24.27
Stock Price
54.40
Market Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 12.23B, a decrease of -25.96%. That is a compound annual growth rate of -7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 12.23B | 7.20% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 341.39B |
| Shenzhen Mindray Bio-Medical Electronics | 276.44B |
| WuXi AppTec | 174.93B |
| Zhangzhou Pientzehuang Pharmaceutical., | 126.08B |
| Aier Eye Hospital Group | 118.54B |
| Shanghai United Imaging Healthcare | 113.02B |
| Sichuan Biokin Pharmaceutical | 106.85B |
| Yunnan Baiyao Group Co.,Ltd | 101.22B |